Viewing SEC Facts Units
Company Name:
Akari Therapeutics, Plc
CIK:
1541157
Start Filing Date:
2017-04-01
End Filing Date:
2017-06-30
ACCN:
0001144204-17-042102
Value:
$ 1,177,693,383
Value Error:
$ None
Created By:
Date Filed:
2017-08-10
FY:
2017
Fiscal Period:
Q2
Frame:
CY2016Q2
Type:
us-gaap
Form:
6-K
Units:
shares